I haven't reviewed this data for a long time, but do vaguely remember that there is some evidence of somewhat better functional outcomes, but the trade-off is bleeding risk. Kolata minimized bleeding risk in her story, suggesting that somehow it is going away.
So far, I haven't seen any pushback from the skeptics, so the story unopposed suggests once again the nasty pharma-scolds are preventing people from getting miraculous therapy.